Skip to main content
Log in

Solid Self-Microemulsifying Formulation for Candesartan Cilexetil

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

Sparingly, water-soluble drugs such as candesartan cilexetil offer challenges in developing a drug product with adequate bioavailability. The objective of the present study was to develop and characterize self-microemulsifying drug delivery system (SMEDDS) of candesartan cilexetil for filling into hard gelatin capsules. Solubility of candesartan cilexetil was evaluated in various nonaqueous careers that included oils, surfactants, and cosurfactants. Pseudoternary phase diagrams were constructed to identify the self-microemulsification region. Four self-microemulsifying formulations were prepared using mixtures of oils, surfactants, and cosurfactants in various proportions. The self-microemulsification properties, droplet size, and zeta potential of these formulations were studied upon dilution with water. The optimized liquid SMEDDS formulation was converted into free flowing powder by adsorbing onto a solid carrier for encapsulation. The dissolution characteristics of solid intermediates of SMEDDS filled into hard gelatin capsules was investigated and compared with liquid formulation and commercial formulation to ascertain the impact on self-emulsifying properties following conversion. The results indicated that solid intermediates showed comparable rate and extent of drug dissolution in a discriminating dissolution medium as liquid SMEDDS indicating that the self-emulsifying properties of SMEDDS were unaffected following conversion. Also, the rate and extent of drug dissolution for solid intermediates was significantly higher than commercial tablet formulation. The results from this study demonstrate the potential use of SMEDDS as a means of improving solubility, dissolution, and concomitantly the bioavailability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Robinson JR. Introduction: semi-solid formulations for oral drug delivery. Bull Tech Gattefosse. 1996;89:11–3.

    Google Scholar 

  2. Aungst BJ. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J Pharm Sci. 1993;82:979–87.

    Article  CAS  PubMed  Google Scholar 

  3. Constantinides PP. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res. 1995;12:1561–72.

    Article  CAS  PubMed  Google Scholar 

  4. Pouton CW. Formulation of self-emulsifying drug delivery systems. Adv Drug Del Rev. 1997;25:47–58.

    Article  CAS  Google Scholar 

  5. Shah NH, Carvajal MT, Patel CI, Infeld MH, Malick AW. Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm. 1994;106:15–23.

    Article  CAS  Google Scholar 

  6. Farah N, Laforet JP, Denis J. Self-micro emulsifying drug delivery systems (SMEDDS) for improving dissolution and bioavailability of poorly soluble active ingredients. B. T. Gattefossé 1994;87:41-47.

    CAS  Google Scholar 

  7. Craig DQM, Barket SA, Banning D, Booth SW. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequencies dielectric spectroscopy. Int J Pharm. 1995;114:103–10.

    Article  CAS  Google Scholar 

  8. Gershanik T, Benita S. Self-dispersion lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm. 2000;50:179–88.

    Article  CAS  PubMed  Google Scholar 

  9. Tarr BD, Yalkowsky SH. Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size. Pharm Res. 1989;6:40–3.

    Article  CAS  PubMed  Google Scholar 

  10. Neslihan GR, Simon B. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004;58:173–82.

    Article  Google Scholar 

  11. Charman WN, Stella VJ. Transport of lipophilic molecules by the intestinal lymphatic system. Adv Drug Del Rev. 1991;7:1–14.

    Article  CAS  Google Scholar 

  12. Wu W, Wang Y, Que L. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur J Pharm Biopharm. 2006;63:288–94.

    Article  CAS  PubMed  Google Scholar 

  13. Ito Y, et al. Oral solid gentamicin preparation using emulsifier and adsorbent. J Control Release. 2005;105:23–31.

    Article  CAS  PubMed  Google Scholar 

  14. Lindmark T, Nikkila T, Artursson P. Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 monolayers. J Pharmacol Exp Ther. 1995;275:958–64.

    CAS  PubMed  Google Scholar 

  15. Eccleston GM. Microemulsions encyclopedia of pharmaceutical technology, vol 9. New York: Marcel Dekker; 1992. p. 375–421.

    Google Scholar 

  16. Wei LL, Sun PN, Nie SF, Pan WS. Preparation and evaluation of SEDDS and SMEDDS containing Carvedilol. Drug Dev Ind Pharm. 2005;31:785–94.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Raviraj Pillai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nekkanti, V., Karatgi, P., Prabhu, R. et al. Solid Self-Microemulsifying Formulation for Candesartan Cilexetil. AAPS PharmSciTech 11, 9–17 (2010). https://doi.org/10.1208/s12249-009-9347-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-009-9347-6

Key words

Navigation